ATE357447T1 - Inhibitoren des papilloma-virus - Google Patents

Inhibitoren des papilloma-virus

Info

Publication number
ATE357447T1
ATE357447T1 AT01271377T AT01271377T ATE357447T1 AT E357447 T1 ATE357447 T1 AT E357447T1 AT 01271377 T AT01271377 T AT 01271377T AT 01271377 T AT01271377 T AT 01271377T AT E357447 T1 ATE357447 T1 AT E357447T1
Authority
AT
Austria
Prior art keywords
optionally
het
substituted
heteroatom
unsaturated
Prior art date
Application number
AT01271377T
Other languages
English (en)
Inventor
Christiane Yoakim
Bruno Hache
William W Ogilvie
Jeffrey O'meara
Peter White
Nathalie Goudreau
Original Assignee
Boehringer Ingelheim Ca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Ca Ltd filed Critical Boehringer Ingelheim Ca Ltd
Application granted granted Critical
Publication of ATE357447T1 publication Critical patent/ATE357447T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/94Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT01271377T 2000-12-18 2001-12-14 Inhibitoren des papilloma-virus ATE357447T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US25670600P 2000-12-18 2000-12-18

Publications (1)

Publication Number Publication Date
ATE357447T1 true ATE357447T1 (de) 2007-04-15

Family

ID=22973265

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01271377T ATE357447T1 (de) 2000-12-18 2001-12-14 Inhibitoren des papilloma-virus

Country Status (12)

Country Link
EP (1) EP1345943B1 (de)
JP (1) JP4458745B2 (de)
AT (1) ATE357447T1 (de)
AU (1) AU2002218897A1 (de)
CA (1) CA2430909C (de)
DE (1) DE60127451T2 (de)
ES (1) ES2282196T3 (de)
HU (1) HUP0303418A3 (de)
IL (1) IL156191A0 (de)
MX (1) MXPA03005479A (de)
NZ (1) NZ526978A (de)
WO (1) WO2002050082A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7167801B2 (en) * 2001-07-12 2007-01-23 Boehringer Ingelheim (Canada) Ltd. Method of identifying potential inhibitors of human papillomavirus protein E2 using x-ray atomic coordinates
EP1474690B1 (de) * 2002-02-07 2010-10-13 Boehringer Ingelheim (Canada) Ltd. E2-verdrängungs-assay zur identifizierung von hpv-inhibitoren
ATE458485T1 (de) * 2003-07-11 2010-03-15 Proteologics Inc Ubiquitin-ligase-hemmer und verwandte verfahren
WO2011133929A2 (en) * 2010-04-23 2011-10-27 University Of Rochester Reducing transmission of sexually transmitted infections
CN111606914B (zh) * 2019-02-22 2023-01-17 中国科学院昆明植物研究所 [吡咯并呋喃]-螺环茚酮类化合物及药物组合物和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4106283A1 (de) * 1991-02-28 1992-09-03 Boehringer Mannheim Gmbh Verwendung von tricyclischen isoindolinonen als antivirale arzneimittel, sowie neue optisch aktive isoindolinone
WO2000017206A1 (en) * 1998-09-18 2000-03-30 Cubist Pharmaceuticals, Inc. Tetracyclic heterocycles as antimicrobial agents

Also Published As

Publication number Publication date
WO2002050082A3 (en) 2002-12-19
EP1345943A2 (de) 2003-09-24
EP1345943B1 (de) 2007-03-21
DE60127451T2 (de) 2007-11-29
JP4458745B2 (ja) 2010-04-28
NZ526978A (en) 2005-12-23
DE60127451D1 (de) 2007-05-03
IL156191A0 (en) 2003-12-23
CA2430909C (en) 2010-12-14
MXPA03005479A (es) 2004-05-31
ES2282196T3 (es) 2007-10-16
CA2430909A1 (en) 2002-06-27
AU2002218897A1 (en) 2002-07-01
WO2002050082A2 (en) 2002-06-27
JP2004515555A (ja) 2004-05-27
HUP0303418A3 (en) 2007-05-02
HUP0303418A2 (hu) 2004-01-28

Similar Documents

Publication Publication Date Title
HRP20020541B1 (en) Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors
HRP20031098B1 (en) Beta-amino tetrahydroimidazo (1,2-a) pyrazines and tetrahydrotrioazolo (4,3-a) pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
EA200100755A1 (ru) 4-оксо-1,4-дигидро-3-хинолинкарбоксамиды как антивирусные агенты
BR0309447A (pt) Composto, agente, processos para a preparação dos mesmos, e para o combate do crescimento de plantas indesejadas, e, uso do composto
PE20011055A1 (es) Compuestos de imidazolidin 2,4-diona sustituida y procedimientos para su preparacion
ATE258552T1 (de) Oxazolidinon-derivate als antibiotika, verfahren zu ihrer herstellung und diese derivate enthaltende pharmazeutische zusammensetzungen
DK633088A (da) Kollagenaseinhibitorer
ES2188194T3 (es) 1,8-naftiridin-4(1h)-onas sustituidas como inhibidores de la fosfodiesterasa 4.
DK159148C (da) Analogifremgangsmaade til fremstilling af tranexamsyrederivater
DE60006099D1 (de) Chinolinderivate als mek enzym-inhibitoren
PT1259484E (pt) Carboxamidas uteis como inibidores de proteina de transferencia de triglicerido microsomal e de secrecao de apolipoproteina b
DE69122941D1 (de) Piperazinderivate
SE9703377D0 (sv) New compounds
NZ513594A (en) Heterocyclic compounds, intermediates thereof and elastase inhibitors
ATE357447T1 (de) Inhibitoren des papilloma-virus
RU2004131645A (ru) Кремнийсодержащие производные фениламидов, полезные в качестве бактерицидов
ATE117986T1 (de) Oxysulfonylharnstoff-acat-inhibitoren.
AR031808A1 (es) 2-piridonas antimicrobianas, sus composiciones y usos
DE60045821D1 (de) Derivate von aromatische heterocyclen enthaltende integraseinhibitoren
ES8203870A1 (es) Procedimiento para preparar difenilbutil-1-acilpiperazinas
ATE3111T1 (de) Verfahren zur herstellung von phenyl-propylmorpholin- und -piperidin-derivaten.
SE8405275D0 (sv) 1,2-dithiolan derivatives, processes for their production, pharmaceutical compositions containing them and their use
NO914577L (no) Fremgangsmaate for fremstilling av heterocyklisk substituerte piperazinoalkylbenzoksazin- og -tiazinforbindelser
ATE40117T1 (de) O-substituierte 3-oxypyridiniumsalze, verfahren zu ihrer herstellung und ihre verwendung als fungizide fuer den pflanzenschutz.
ES448439A1 (es) Procedimiento para la preparacion de nuevos de diacina.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1345943

Country of ref document: EP